Neurology studies can be difficult to navigate, but PPD can make it easier. We fully understand this environment, so you can depend on PPD to start trials quickly and keep them on track – while staying abreast of all the changes along the way. Our extensive experience spans more than 110 trials in the past five years, involving key neurological indications such as:
- multiple sclerosis
- Alzheimer's disease
- Parkinson’s disease and dementia
This experience will help you develop the best strategies to conduct studies and better navigate the regulatory process for the benefit of your study.
Read a case study about Alzheimer's disease.